Oxybutynin lessens hot flash frequency, improves breast cancer survivor quality of life, Mayo-led study finds

SAN ANTONIO — Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. These findings were presented at the 2018 San … Continue reading Oxybutynin lessens hot flash frequency, improves breast cancer survivor quality of life, Mayo-led study finds